
Loading, please wait...

Loading, please wait...

Salmonella remains a primary cause of zoonotic foodborne disease. This makes the search for effective Salmonella antibiotic alternatives a public health priority. Specifically, avian strains like S. Pullorum cause high mortality in chicks. Meanwhile, paratyphoid strains contaminate the human food chain. Consequently, overusing antibiotics in poultry has led to widespread multi-drug resistance. Therefore, clinicians must understand how non-drug interventions in farming impact human health.
Probiotics and phytobiotics represent promising tools to enhance immune responses. These additives successfully stabilize gut microbiota and reduce pathogen shedding. Additionally, bacteriophages are specific viruses that target pathogens while leaving beneficial flora intact. However, the efficacy of these treatments depends heavily on the timing and dosage. Notably, research indicates that combining multiple interventions creates a synergistic effect. Furthermore, nanoparticles and egg yolk immunoglobulins help manage persistent asymptomatic carriers. Such biocontrol measures effectively replace conventional antibiotics in therapeutic settings. Moreover, these strategies lower the risk of intestinal dysbiosis in the birds. Ultimately, these innovations support the global One Health initiative. In conclusion, adopting these alternatives ensures a safer food supply for everyone.
Probiotics enhance the immune response and help maintain a healthy gut microbiome, which prevents pathogenic Salmonella from colonizing the intestinal tract.
Yes, bacteriophages are highly specific to target bacteria and do not harm the bird's natural microflora or create the same resistance risks as antibiotics.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical or veterinary advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider or veterinarian with any questions. Refer to the latest local and national guidelines for clinical practice.
References
El-Shall NA et al. Salmonella infection in chickens: pathogen, pathogenesis, and dietary non-drug feed additives as alternatives to antibiotics - a comprehensive review. Folia Microbiol (Praha). 2026 Feb 28. doi: 10.1007/s12223-025-01403-z. PMID: 41762430.
Shil S et al. Antimicrobial Resistance in Salmonella from Indian Poultry: Trends, Challenges, and One Health Perspectives. Journal of Pure and Applied Microbiology. 2026 Feb 25.
Almayman SMS & Tech SL. Uses of Bacteriophage on Salmonella in the Poultry Industry. Journal of Posthumanism. 2025;5(8):124-158.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Learn how probiotics and bacteriophages act as Salmonella antibiotic alternatives to reduce resistance and improve food safety in the poultry industry....
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today